GHK-Cu
All information below is drawn from preclinical research literature and is provided for educational and informational purposes only. It does not constitute medical advice, imply therapeutic outcomes, or endorse any specific application.
Chemical Identification
Property
Value
Overview
General Research Context
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It was originally isolated from human blood plasma in the 1970s. In preclinical research, GHK-Cu has been studied in the context of tissue remodeling assays, extracellular matrix composition studies, and copper-dependent enzymatic pathways.
The compound is examined as a copper-delivery peptide complex, with research interest focused on its chelation properties and interactions with copper-dependent enzymes in isolated cellular models.
Areas of Investigation
Observed Interactions and Background
The biological activity of GHK-Cu is associated with the peptide sequence's high affinity for copper ions (Cu2+). In mammalian biochemistry, copper serves as a cofactor for enzymes including lysyl oxidase. The GHK sequence forms a stable chelate that has been studied for its copper-transport characteristics in preclinical assay systems.
In isolated fibroblast culture assays, researchers have observed changes in collagen synthesis markers and glycosaminoglycan production following GHK-Cu administration. Gene expression studies have reported that GHK-Cu interacts with pathways associated with the Transforming Growth Factor-beta (TGF-β) signaling cascade. These observations are limited to in vitro and preclinical contexts.
Laboratory Notes
Synthesis and Stability Notes
The base tripeptide (GHK) is easily, rapidly, and inexpensively synthesized in high yields via standard SPPS protocols. The subsequent incorporation of the active copper ion is achieved through precise stoichiometric incubation of the peptide in an aqueous solution with a purified copper salt (such as copper acetate). The resultant complex forms highly stable, distinctively deep-blue crystals upon lyophilization. The molecule is robust in a dry state but requires protection from extreme chelating agents in solution (such as EDTA) which possess the necessary binding affinity to strip the bound copper ion from the peptide lattice.
Disclaimer: All information provided herein is strictly for educational and laboratory research reference purposes only. Saga does not endorse, interpret, or evaluate these preclinical studies for any specific in vivo application or human therapeutic outcome.